See All Slides - tctmd.com

Slides

Presentation TCT 2013

Left Atrial Appendage Occlusion Devices: Techniques and Different Devices

Presenter: Horst Sievert

October 29, 2013

Presentation

Treatment Options in Calcified Peripheral Vessels

Presenter: William Gray

October 29, 2013

Presentation TCT 2013

Case #2: Complex Primary PCI in a “Complex” Patient

Presenter: Roman Miklik

October 29, 2013

Presentation TCT 2013

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Presenter: Robert Gil

October 29, 2013

Presentation TCT 2013

Selective Use of Intravascular Imaging and Physiologic Lesion Assessment to Improve Patient Outcomes

Presenter: Gary Mintz

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

The Science and Rationale of Bioabsorbable Vascular Scaffolds in the Treatment of Coronary Artery Disease

Presenter: Gabriel Maluenda

October 29, 2013

Presentation TCT 2013

Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study

Presenter: Michael Reardon

October 29, 2013

Presentation

Coronary Artery Disease and CTA-Based Imaging: What Does It Mean?

Presenter: James Min

October 29, 2013

Presentation TCT 2013

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Presenter: Michael Rinaldi

October 29, 2013

Advertisement

Slides

Left Atrial Appendage Occlusion Devices: Techniques and Different Devices

Treatment Options in Calcified Peripheral Vessels

Case #2: Complex Primary PCI in a “Complex” Patient

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Selective Use of Intravascular Imaging and Physiologic Lesion Assessment to Improve Patient Outcomes

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

The Science and Rationale of Bioabsorbable Vascular Scaffolds in the Treatment of Coronary Artery Disease

Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study

Coronary Artery Disease and CTA-Based Imaging: What Does It Mean?

TCT-1. Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content